Company Profile
ImmunoGen Stock Price, News & Analysis
- Ticker:
- IMGN
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, ImmunoGen is followed within the immunology universe for its exposure to chronic-disease treatment demand and catalyst-driven clinical updates.
Why the stock is moving
IMGN is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
ImmunoGen is an immunology-oriented biopharmaceutical company focused on inflammatory and immune-mediated disease programs, where each new data point can reshape expectations for the pipeline and the next catalyst window.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, ImmunoGen is followed within the immunology universe for its exposure to chronic-disease treatment demand and catalyst-driven clinical updates.
Business Model Characteristics
ImmunoGen is a pipeline-led immunology story, so the market tends to track readouts, regulatory milestones, and how the company expands from one immune program to the next.
Position Within the Biotechnology Landscape
Compared with more mature peers, ImmunoGen sits close to the development side of the biotech landscape, where immunology data can change sentiment quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does ImmunoGen do?
ImmunoGen is an immunology-oriented biopharmaceutical company focused on inflammatory and immune-mediated disease programs, where each new data point can reshape expectations for the pipeline and the next catalyst window.
On which exchange is IMGN stock listed?
ImmunoGen (IMGN) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, ImmunoGen is followed within the immunology universe for its exposure to chronic-disease treatment demand and catalyst-driven clinical updates., Biotechnology.
What is ImmunoGen?
ImmunoGen is an immunology-oriented biopharmaceutical company focused on inflammatory and immune-mediated disease programs, where each new data point can reshape expectations for the pipeline and the next catalyst window.
Which conditions is ImmunoGen targeting with ImmunoGen?
ImmunoGen is associated with immunology based on its company overview and current catalyst commentary.